Oncternal Therapeutics Inc (ONCT) — Cash Flow Quality Index
Oncternal Therapeutics Inc (ONCT) has a Cash Flow Quality Index of -2.27x as of March 2016. Operating cash flow of $-4.78 Million is below net income of $2.11 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Oncternal Therapeutics Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oncternal Therapeutics Inc Cash Flow Quality Index (2010–2010)
Historical Cash Flow Quality Index for Oncternal Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ONCT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Oncternal Therapeutics Inc (2010–2010)
Year-by-year earnings quality comparison for Oncternal Therapeutics Inc. For live market cap and the full company financial profile, see Oncternal Therapeutics Inc (ONCT) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | -2.00x | $-30.53 Million | $15.29 Million | — |